(Q34002872)

30 July 2017

1 reference

title

Schizophrenia and the alpha7 nicotinic acetylcholine receptor (English)

1 reference

30 July 2017

0 references

Laura F Martin

1

1 reference

30 July 2017

Robert Freedman

series ordinal

2

1 reference

30 July 2017

publication date

1 January 2007

1 reference

International Review of Neurobiology

30 July 2017

published in

1 reference

30 July 2017

volume

78

1 reference

30 July 2017

page(s)

225-246

1 reference

Inhibition of nitric oxide synthase prevents alpha 7 nicotinic receptor-mediated restoration of inhibitory auditory gating in rat hippocampus

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Readiness to stop smoking in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Smoking cessation treatment for patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Neurophysiologic studies of sensory gating in schizophrenia: comparison of auditory and visual responses

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Normalization of auditory physiology by cigarette smoking in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Improved p50 auditory gating with ondansetron in medicated schizophrenia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Contribution of nicotinic receptors to the function of synapses in the central nervous system: the action of choline as a selective agonist of alpha 7 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Neuronal nicotinic receptors in synaptic functions in humans and rats: physiological and clinical relevance.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

alpha7 nicotinic acetylcholine receptors and modulation of gabaergic synaptic transmission in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Treatment of neuroleptic-induced akathisia with nicotine patches

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Olanzapine effects on auditory sensory gating in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Effects of nicotine on leading saccades during smooth pursuit eye movements in smokers and nonsmokers with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Basic cardiovascular research and its implications for the medicinal use of nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Restoration of sensory gating of auditory evoked response by nicotine in fimbria-fornix lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Replication and extension of P50 findings in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

No increased levels of the nicotine metabolite cotinine in smokers with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Human alpha 7 nicotinic acetylcholine receptor responses to novel ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Nicotine impairs endothelium-dependent dilatation in human veins in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Molecular cloning and chromosomal localization of the human alpha 7-nicotinic receptor subunit gene (CHRNA7).

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

P50 suppression among schizophrenia and normal comparison subjects: a methodological analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Poor P50 suppression among schizophrenia patients and their first-degree biological relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Antipsychotic medication and smoking prevalence in acutely hospitalized patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Use of a neurophysiological trait in linkage analysis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Nicotine increases oxidative stress, activates NF-kappaB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

No evidence for linkage between schizophrenia and markers at chromosome 15q13-14.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Smoking, smoking withdrawal and schizophrenia: case reports and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Schizophrenia and smoking: an epidemiological survey in a state hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Does clozapine decrease smoking?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Linkage of M5 muscarinic and alpha7-nicotinic receptor genes on 15q13 to schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Cigarette smoking and neuroleptic-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Effects of nicotine on heart dimensions and blood volume in male and female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Impairment of nitric oxide synthase-dependent dilatation of cerebral arterioles during infusion of nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Schizophrenia and nicotinic receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7)

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Effects of smoking abstinence on visuospatial working memory function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Cigarette smoking: implications for psychiatric illness

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

What are the functional consequences of neurocognitive deficits in schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Nicotinic receptor desensitization and sensory gating deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Nicotine modulation of apoptosis in human coronary artery endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Effects of nicotine on cognitive deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Tropisetron improves deficient inhibitory auditory processing in DBA/2 mice: role of alpha 7 nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

GABAB antagonists diminish the inhibitory gating of auditory response in the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Signalling pathways involved in nicotine regulation of apoptosis of human lung cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

The promoter -194 C polymorphism of the nicotinic alpha 7 receptor gene has a protective effect against the P50 sensory gating deficit

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Prevalence of smoking among psychiatric outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Nicotine effects on brain function and functional connectivity in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Inhibition and disinhibition of pyramidal neurons by activation of nicotinic receptors on hippocampal interneurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Sensory gating deficits in schizophrenia: new results

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21).

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Isolation and structure of a hoplonemertine toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Hydroxy metabolites of the Alzheimer's drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride (GTS-21): their molecular properties, interactions with brain nicotinic receptors, and brain penetration

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Tropisetron improves deficits in auditory P50 suppression in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Nicotine reduces antisaccade errors in task impaired schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Further investigation of a chromosome 15 locus in schizophrenia: Analysis of affected sibpairs from the NIMH genetics initiative

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Nicotinic acetylcholine involvement in cognitive function in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Development of nicotinic drug therapy for cognitive disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Nicotine-haloperidol interactions and cognitive performance in schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Suggestive evidence for linkage of schizophrenia to markers at chromosome 15q13-14 in Taiwanese families

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Schizophrenia and tobacco smoking in a Spanish psychiatric hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

A concordance study of three electrophysiological measures in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Cholinergic gating of response to auditory stimuli in rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Smoking and malignancy in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Anabasine, a selective nicotinic acetylcholine receptor agonist, antagonizes MK-801-elicited mouse popping behavior, an animal model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Smoking and therapeutic response to clozapine in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Neuroprotective effects of 2,4-dimethoxybenzylidene anabaseine (DMXB) and tetrahydroaminoacridine (THA) in neocortices of nucleus basalis lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

(-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Nicotine improves delayed recognition in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Auditory P50 in schizophrenics on clozapine: improved gating parallels clinical improvement and changes in plasma 3-methoxy-4-hydroxyphenylglycol.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

No evidence for linkage of the CHRNA7 gene region in Canadian schizophrenia families

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Nicotine dependence, midbrain dopamine systems and psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Differential effects of cigarette smoking on performance of a smooth pursuit and a saccadic eye movement task in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

alpha7 receptor-selective agonists and modes of alpha7 receptor activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Molecular dissection of tropisetron, an alpha7 nicotinic acetylcholine receptor-selective partial agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

The alpha7 nicotinic acetylcholine receptor in schizophrenia: decreased mRNA levels in peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Evidence for bilineal inheritance of physiological indicators of risk in childhood-onset schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Adjuvant galantamine administration improves negative symptoms in a patient with treatment-refractory schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Effects of alpha 4/beta 2- and alpha 7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

The cost of cognitive impairment in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

The effects of nicotine on specific eye tracking measures in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Intragastric DMXB-A, an alpha7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Motivational interviewing with personalized feedback: a brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Selective alpha 7 nicotinic receptor stimulation normalizes chronic cocaine-induced loss of hippocampal sensory inhibition in C3H mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Splitting schizophrenia: periodic catatonia-susceptibility locus on chromosome 15q15

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Smoking and cognitive deficits in schizophrenia: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Neurobiology of smooth pursuit eye movement deficits in schizophrenia: an fMRI study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

FMRI of response to nicotine during a smooth pursuit eye movement task in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Examination of genetic linkage of chromosome 15 to schizophrenia in a large Veterans Affairs Cooperative Study sample

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Nicotine counteracts midbrain dopamine cell dysfunction induced by prefrontal cortex inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Hippocampal function and schizophrenia. Experimental psychological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Codistribution of a sensory gating deficit and schizophrenia in multi-affected families

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Replication of a P50 auditory gating deficit in Australian patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Comparison of cognitive performances during a placebo period and an atypical antipsychotic treatment period in schizophrenia: critical examination of confounds

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Mecamylamine reversal by nicotine and by a partial alpha7 nicotinic acetylcholine receptor agonist (GTS-21) in rabbits tested with delay eyeblink classical conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Evidence for linkage disequilibrium between the alpha 7-nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azorean families

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Reliabilities and intercorrelations of reported and objective measures of smoking in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Serious mental illness and tobacco addiction: a model program to address this common but neglected issue

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Schizophrenia and the motivation for smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Smoking and mental illness: A population-based prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

P50 suppression in recent-onset schizophrenia: clinical correlates and risperidone effects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978008-4

7 January 2021

10.1016/S0074-7742(06)78008-4

Identifiers

DOI

1 reference

30 July 2017

1 reference